Evidence map›Paper›PMID 40406095›Full record

ArticleFrontiers in immunology2025

Baicalin enhances respiratory mucosal immunity by modulating antiviral protein expression and T-cell homeostasis during H9N2 infection.

Zhenyi Liu, Haotong Guo, Yan Zhi, Xiaorui Jiang, Qian Zhang

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhenyi Liu *College of Animal Science and Technology, Beijing University of Agriculture, Beijing, China.
Haotong Guo *College of Animal Science and Technology, Beijing University of Agriculture, Beijing, China.
Yan ZhiCollege of Animal Science and Technology, Beijing University of Agriculture, Beijing, China.
Xiaorui JiangYanTai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, China.
Qian ZhangCollege of Animal Science and Technology, Beijing University of Agriculture, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The H9N2 avian influenza virus, although not highly pathogenic, still poses ongoing risks to poultry health and food security due to its ability to resist vaccines and its potential to spread to humans. Methods: This study investigated the effects of baicalin, a flavonoid derived from Results: Baicalin treatment enhanced the expression of antiviral proteins Mx1 and PKR in a dose- and time-dependent manner, helping to counteract the virus's suppression of these defense proteins. In addition to strengthening this epithelial barrier, baicalin has both antiviral and immune-regulating effects: it directly blocks viral replication and helps restore the CD4+/CD8+ T cell ratio in H9N2-infected mice. Most importantly, baicalin reduces lung damage and spleen shrinkage while keeping the immune system balanced. These results show that baicalin enhances mucosal antiviral defenses by simultaneously regulating innate antiviral pathways (Mx1 and PKR) and restoring adaptive immune balance (CD4+/CD8+ T-cell ratio). Discussion: These dual protective effects highlight baicalin's potential as a natural therapeutic strategy for improving mucosal immunity against vaccine-resistant influenza viruses such as H9N2, contributing valuable insights into plant-derived immunomodulatory approaches against emerging zoonotic viral threats.

Indexed as

Antiviral AgentsFlavonoidsImmunity, MucosalInfluenza A Virus, H9N2 SubtypeOrthomyxoviridae InfectionsRespiratory MucosaT-LymphocytesAnimalsCell LineeIF-2 KinaseFemaleHomeostasisHumansMiceMice, Inbred BALB CVirus ReplicationAntiviral AgentsbaicalineIF-2 KinaseFlavonoidsantiviral proteinsbaicalinH9N2 avnia influenza virusMX1natural immunomodulatorsPKRrespiratory mucosal immunity

Identifiers

PMID40406095
PMCPMC12095332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.